Angiopoietin-2 Attenuates Angiotensin II-induced Aortic Aneurysm and Atherosclerosis in Apolipoprotein E-deficient Mice

Overview

Journal Sci Rep

Specialty Science

Date 2016 Oct 22

PMID 27767064

Citations 15

Authors

Hongyou Yu

Corey S Moran

Alexandra F Trollope

Lynn Woodward

Robert Kinobe

Catherine M Rush

Jonathan Golledge

Affiliations

Soon will be listed here.

Abstract

Angiogenesis and inflammation are implicated in aortic aneurysm and atherosclerosis and regulated by angiopoietin-2 (Angpt2). The effect of Angpt2 administration on experimental aortic aneurysm and atherosclerosis was examined. Six-month-old male apolipoprotein E deficient (ApoE) mice were infused with angiotensin II (AngII) and administered subcutaneous human Fc-protein (control) or recombinant Angpt2 (rAngpt2) over 14 days. Administration of rAngpt2 significantly inhibited AngII-induced aortic dilatation and rupture of the suprarenal aorta (SRA), and development of atherosclerosis within the aortic arch. These effects were blood pressure and plasma lipoprotein independent and associated with Tie2 activation and down-regulation of monocyte chemotactic protein-1 (MCP-1) within the SRA. Plasma concentrations of MCP-1 and interleukin-6 were significantly lower in mice receiving rAngpt2. Immunostaining for the monocyte/macrophage marker MOMA-2 and the angiogenesis marker CD31 within the SRA were less in mice receiving rAngpt2 than controls. The percentage of inflammatory (Ly6C) monocytes within the bone marrow was increased while that in peripheral blood was decreased by rAngpt2 administration. In conclusion, administration of rAngpt2 attenuated angiotensin II-induced aortic aneurysm and atherosclerosis in ApoE mice associated with reduced aortic inflammation and angiogenesis. Up-regulation of Angpt2 may have potential therapeutic value in patients with aortic aneurysm and atherosclerosis.

Citing Articles

Angiopoietin-2: A Therapeutic Target for Vascular Protection in Hutchinson-Gilford Progeria Syndrome.

Vakili S, Cao K Int J Mol Sci. 2025; 25(24.

PMID: 39769300 PMC: 11676795. DOI: 10.3390/ijms252413537.

Angiogenesis in Aortic Aneurysm and Dissection: A Literature Review.

Jia Y, Li D, Yu J, Jiang W, Liu Y, Li F Rev Cardiovasc Med. 2024; 24(8):223.

PMID: 39076698 PMC: 11266809. DOI: 10.31083/j.rcm2408223.

Changes to Urinary Proteome in High-Fat-Diet Mice.

Hua Y, Meng W, Wei J, Liu Y, Gao Y Biomolecules. 2022; 12(11).

PMID: 36358920 PMC: 9687344. DOI: 10.3390/biom12111569.

DNA methylation alternation in Stanford- A acute aortic dissection.

Chen Y, Xu X, Chen Z, Huang B, Wang X, Fan X BMC Cardiovasc Disord. 2022; 22(1):455.

PMID: 36309656 PMC: 9618190. DOI: 10.1186/s12872-022-02882-5.

Immune and inflammatory mechanisms of abdominal aortic aneurysm.

Marquez-Sanchez A, Koltsova E Front Immunol. 2022; 13:989933.

PMID: 36275758 PMC: 9583679. DOI: 10.3389/fimmu.2022.989933.

References

Scharpfenecker M, Fiedler U, Reiss Y, Augustin H . The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005; 118(Pt 4):771-80. DOI: 10.1242/jcs.01653. View

Murakami M . Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med. 2011; 2012:293641. PMC: 3236483. DOI: 10.1155/2012/293641. View

Cao R, Amand T, Ford M, Piomelli U, Funk C . The Murine Angiotensin II-Induced Abdominal Aortic Aneurysm Model: Rupture Risk and Inflammatory Progression Patterns. Front Pharmacol. 2011; 1:9. PMC: 3112241. DOI: 10.3389/fphar.2010.00009. View

Daly C, Pasnikowski E, Burova E, Wong V, Aldrich T, Griffiths J . Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci U S A. 2006; 103(42):15491-6. PMC: 1592534. DOI: 10.1073/pnas.0607538103. View

Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G . Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005; 314(2):738-44. DOI: 10.1124/jpet.105.086553. View

Imhof B, Aurrand-Lions M . Angiogenesis and inflammation face off. Nat Med. 2006; 12(2):171-2. DOI: 10.1038/nm0206-171. View

Golledge J, Clancy P, Yeap B, Hankey G, Norman P . Increased serum angiopoietin-2 is associated with abdominal aortic aneurysm prevalence and cardiovascular mortality in older men. Int J Cardiol. 2012; 167(4):1159-63. DOI: 10.1016/j.ijcard.2012.03.120. View

Daugherty A, Manning M, Cassis L . Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000; 105(11):1605-12. PMC: 300846. DOI: 10.1172/JCI7818. View

Lewis C, de Palma M, Naldini L . Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 2007; 67(18):8429-32. DOI: 10.1158/0008-5472.CAN-07-1684. View

10.

Daugherty A, Rateri D, Charo I, Owens A, Howatt D, Cassis L . Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond). 2010; 118(11):681-9. PMC: 2841499. DOI: 10.1042/CS20090372. View

11.

Serbina N, Pamer E . Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006; 7(3):311-7. DOI: 10.1038/ni1309. View

12.

Ahmed A, Fujisawa T, Niu X, Ahmad S, Al-Ani B, Chudasama K . Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. Circ Res. 2009; 104(12):1333-6. PMC: 2938017. DOI: 10.1161/CIRCRESAHA.109.196154. View

13.

Golledge J, Norman P . Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011; 217(1):57-63. DOI: 10.1016/j.atherosclerosis.2011.03.006. View

14.

Reed D, Reed C, Stemmermann G, Hayashi T . Are aortic aneurysms caused by atherosclerosis?. Circulation. 1992; 85(1):205-11. DOI: 10.1161/01.cir.85.1.205. View

15.

Fiedler U, Augustin H . Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006; 27(12):552-8. DOI: 10.1016/j.it.2006.10.004. View

16.

Seto S, Krishna S, Yu H, Liu D, Khosla S, Golledge J . Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice. PLoS One. 2013; 8(3):e58481. PMC: 3587590. DOI: 10.1371/journal.pone.0058481. View

17.

Lobov I, Brooks P, Lang R . Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002; 99(17):11205-10. PMC: 123234. DOI: 10.1073/pnas.172161899. View

18.

Thurston G, Daly C . The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med. 2012; 2(9):a006550. PMC: 3426817. DOI: 10.1101/cshperspect.a006650. View

19.

Armstrong A, Voyles S, Armstrong E, Fuller E, Rutledge J . Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011; 63(1):1-9. DOI: 10.1016/j.jdermsci.2011.04.007. View

20.

Moran C, Jose R, Moxon J, Roomberg A, Norman P, Rush C . Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Arterioscler Thromb Vasc Biol. 2013; 33(4):814-21. DOI: 10.1161/ATVBAHA.112.301006. View